Magnus Polla

575 total citations
15 papers, 439 citations indexed

About

Magnus Polla is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Magnus Polla has authored 15 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Magnus Polla's work include Receptor Mechanisms and Signaling (5 papers), Peptidase Inhibition and Analysis (4 papers) and Computational Drug Discovery Methods (4 papers). Magnus Polla is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Peptidase Inhibition and Analysis (4 papers) and Computational Drug Discovery Methods (4 papers). Magnus Polla collaborates with scholars based in Sweden, Belgium and United Kingdom. Magnus Polla's co-authors include Torbjörn Frejd, Alleyn T. Plowright, Lauren Drowley, Richard J. Mills, Maryam Clausen, Aurélie Bornot, Mei Ding, Benjamin L. Parker, James E. Hudson and David A. Elliott and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Chemical Communications.

In The Last Decade

Magnus Polla

15 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magnus Polla Sweden 9 228 116 102 93 61 15 439
Saul Needle United States 10 300 1.3× 119 1.0× 184 1.8× 40 0.4× 24 0.4× 11 603
Ellen Rohde United States 12 257 1.1× 72 0.6× 25 0.2× 89 1.0× 66 1.1× 21 550
Kamelia Behnia United States 7 72 0.3× 99 0.9× 29 0.3× 83 0.9× 39 0.6× 10 295
Hyo Min Park United States 9 258 1.1× 59 0.5× 45 0.4× 106 1.1× 76 1.2× 11 519
Kent T. Symons United States 8 187 0.8× 37 0.3× 114 1.1× 33 0.4× 54 0.9× 12 394
Motoharu Kakiki Japan 11 113 0.5× 32 0.3× 24 0.2× 136 1.5× 68 1.1× 20 398
Christine Bruun Schiødt Denmark 11 232 1.0× 89 0.8× 54 0.5× 21 0.2× 103 1.7× 16 444
Yongzheng Lu China 13 232 1.0× 68 0.6× 120 1.2× 32 0.3× 36 0.6× 22 500
Maike Zimmermann United States 12 347 1.5× 44 0.4× 29 0.3× 40 0.4× 104 1.7× 20 522
Lixia Zheng China 13 208 0.9× 28 0.2× 19 0.2× 49 0.5× 65 1.1× 30 451

Countries citing papers authored by Magnus Polla

Since Specialization
Citations

This map shows the geographic impact of Magnus Polla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Polla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Polla more than expected).

Fields of papers citing papers by Magnus Polla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Polla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Polla. The network helps show where Magnus Polla may publish in the future.

Co-authorship network of co-authors of Magnus Polla

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Polla. A scholar is included among the top collaborators of Magnus Polla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Polla. Magnus Polla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mills, Richard J., Benjamin L. Parker, Gregory A. Quaife-Ryan, et al.. (2019). Drug Screening in Human PSC-Cardiac Organoids Identifies Pro-proliferative Compounds Acting via the Mevalonate Pathway. Cell stem cell. 24(6). 895–907.e6. 205 indexed citations
2.
Werner, Tessa, Elena S. Reckzeh, Lauren Drowley, et al.. (2019). Toward Second‐Generation Cardiomyogenic and Anti‐cardiofibrotic 1,4‐Dihydropyridine‐Class TGFβ Inhibitors. ChemMedChem. 14(8). 810–822. 8 indexed citations
3.
Sundström, Linda, Monika Sundqvist, Andrea Ahnmark, et al.. (2017). The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1. PLoS ONE. 12(12). e0189060–e0189060. 41 indexed citations
4.
Bergström, Fredrik, Jonas Brånalt, Gunnar Grönberg, et al.. (2016). Macrocyclic Prodrugs of a Selective Nonpeptidic Direct Thrombin Inhibitor Display High Permeability, Efficient Bioconversion but Low Bioavailability. Journal of Medicinal Chemistry. 59(14). 6658–6670. 7 indexed citations
5.
Abrahamsson, Kate, Patrik Andersson, Joakim Bergman, et al.. (2015). Discovery of AZD8165 – a clinical candidate from a novel series of neutral thrombin inhibitors. MedChemComm. 7(2). 272–281. 21 indexed citations
6.
Dahlén, Anders, et al.. (2014). Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa). Bioorganic & Medicinal Chemistry. 22(7). 2261–2268. 13 indexed citations
7.
Nilsson, Ingemar & Magnus Polla. (2012). Composite multi-parameter ranking of real and virtual compounds for design of MC4R agonists: Renaissance of the Free-Wilson methodology. Journal of Computer-Aided Molecular Design. 26(10). 1143–1157. 2 indexed citations
8.
Willemse, Johan, Magnus Polla, Thomas Olsson, & Dirk Hendriks. (2007). Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: Development of highly selective CPU substrates as useful tools for assay development. Clinica Chimica Acta. 387(1-2). 158–160. 9 indexed citations
9.
Willemse, Johan, Magnus Polla, & Dirk Hendriks. (2006). The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays. Analytical Biochemistry. 356(1). 157–159. 16 indexed citations
10.
Polla, Magnus, et al.. (2004). Design and synthesis of potent, orally active, inhibitors of carboxypeptidase U (TAFIa). Bioorganic & Medicinal Chemistry. 12(5). 1151–1175. 52 indexed citations
11.
Wennerberg, Johan, Magnus Polla, & Torbjörn Frejd. (1997). Siamyl Glyoxylate as an Efficient Enophile in the Lewis Acid Mediated Glyoxylate Ene-Reaction with Allylic Ethers. Application to the Synthesis of a Taxol A-Ring Subunit. The Journal of Organic Chemistry. 62(25). 8735–8740. 8 indexed citations
12.
Wennerberg, Johan, Lars Eklund, Magnus Polla, & Torbjörn Frejd. (1997). Rearrangement of p-methoxybenzyl-protected allylic alcohols to aldehydes. Chemical Communications. 445–446. 6 indexed citations
13.
Polla, Magnus, Torbjörn Frejd, Göran Widmalm, et al.. (1993). Lewis Acid Induced Alkoxyalkylation of Allylsilanes with Acetals (the Sakurai Reaction): Regio- and Stereo-chemical Aspects.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 47. 716–720. 3 indexed citations
14.
Polla, Magnus & Torbjörn Frejd. (1993). New synthesis of a taxol A-ring system.. Tetrahedron. 49(13). 2701–2710. 13 indexed citations
15.
Polla, Magnus & Torbjörn Frejd. (1991). Synthesis of optically active cyclohexenol derivatives via enzyme catalyzed ester hydrolysis of 4-acetoxy-3-methyl-2-cyclohexenone. Tetrahedron. 47(30). 5883–5894. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saul Needle Breakdown of academic impact, for papers by Ellen Rohde Breakdown of academic impact, for papers by Kamelia Behnia Breakdown of academic impact, for papers by Hyo Min Park Breakdown of academic impact, for papers by Kent T. Symons Breakdown of academic impact, for papers by Motoharu Kakiki Breakdown of academic impact, for papers by Christine Bruun Schiødt Breakdown of academic impact, for papers by Yongzheng Lu Breakdown of academic impact, for papers by Maike Zimmermann Breakdown of academic impact, for papers by Lixia Zheng
Rankless by CCL
2026